Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  JACC. Heart failure

• Publication date

  2015-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jchf.2015.05.005PMID 26277764
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adjusting Survival Time Estimates in the Presence of Treatment Switching

  2014cited by this paper
• Clinical trial design in contemporary device studies in heart failure: is there a gold standard?

  2014cited by this paper
• Survival with cardiac-resynchronization therapy in mild heart failure.

  2014cited by this paper
• An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure

  2013cited by this paper
• 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

  2013cited by this paper
• 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

  2013cited by this paper
• QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy.

  2013cited by this paper
• Implantable Defibrillators Improve Survival in Patients With Mildly Symptomatic Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the Long-Term Follow-Up of Remodeling in Systolic Left Ventricular Dysfunction (REVERSE)

  2013cited by this paper
• The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure.

  2011cited by this paper
• Cardiac-resynchronization therapy for mild-to-moderate heart failure.

  2010cited by this paper
• Cardiac-resynchronization therapy for the prevention of heart-failure events.

  2009cited by this paper
• Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.

  2009cited by this paper
• Gemcitabine for the treatment of metastatic breast cancer.

  2009cited by this paper
• Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

  2008cited by this paper
• Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure

  2007cited by this paper
• A review and critique of modelling in prioritising and designing screening programmes.

  2007cited by this paper
• The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

  2007cited by this paper
• Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association.

  2007cited by this paper
• Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association.

  2007cited by this paper
• Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular

  2006cited by this paper
• Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial.

  2006cited by this paper
• Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial.

  2005cited by this paper
• The effect of cardiac resynchronization on morbidity and mortality in heart failure.

  2005cited by this paper
• Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial.

  2005cited by this paper
• Cardiac resynchronization therapy (CRT) in heart failure--a model to assess the economic value of this new medical technology.

  2005cited by this paper
• Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

  2004cited by this paper
• Cardiac resynchronization in chronic heart failure.

  2002cited by this paper
• Estimating a treatment effect in survival studies in which patients switch treatment

  2002cited by this paper
• The CARE‐HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end‐points

  2001cited by this paper
• Randomization-based methods for correcting for treatment changes: examples from the Concorde trial.

  1999cited by this paper
• Estimability and estimation of expected years of life lost due to a hazardous exposure.

  1991cited by this paper

• CRT-D or CRT-P: When There Is a Dilemma and How to Solve It

  2025cites this paper
• Mechanical dyssynchrony in patients with chronic heart failure and left bundle branch block

  2024cites this paper
• Linksschenkelstimulation ist der klassischen kardialen Resynchronisationstherapie überlegen

  2024cites this paper
• Role of radionuclide assessment of global and regional mechanical dyssynchrony of the heart in prognosis of cardiac resynchronization therapy in patients with heart failure

  2023cites this paper
• Time-trend treatment effect of cardiac resynchronization therapy with or without defibrillator on mortality: a systematic review and meta-analysis

  2023cites this paper
• Long-Term Beta-Blocker Therapy in Patients With Stable Coronary Artery Disease After Percutaneous Coronary Intervention

  2022cites this paper
• Adjusting Overall Survival Estimates of Macitentan in Pulmonary Arterial Hypertension After Treatment Switching: Results from the SERAPHIN Study

  2022cites this paper
• Cardiac resynchronization therapy outcomes in patients under nonoptimal medical therapy

  2018cites this paper
• Machine Learning Algorithm Predicts Cardiac Resynchronization Therapy Outcomes: Lessons From the COMPANION Trial

  2018cites this paper
• Biventricular Pacing/Cardiac Resynchronization Therapy (CRT)

  2017cites this paper
• Cardiac resynchronization therapy for the treatment of mild heart failure: A review of the clinical data

  2017cites this paper
• Economic Value and Cost-Effectiveness of Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up.

  2017cites this paper
• Long-term efficacy of implantable cardiac resynchronization therapy plus defibrillator for primary prevention of sudden cardiac death in patients with mild heart failure: an updated meta-analysis

  2016influential citation
• What is the cost of non-response to cardiac resynchronization therapy? Hospitalizations and healthcare utilization in the CRT-D population

  2016cites this paper
• Cardiac Resynchronization Therapy for Mild Heart Failure: Compelling Evidence of Long-Term Benefits.

  2015cites this paper
• Importance of Implantable Cardioverter‐Defibrillator Back‐Up in Cardiac Resynchronization Therapy Recipients: A Systematic Review and Meta‐Analysis

  2015cites this paper